Number Т. 9, № 4 (36) 2019

Bevacizumab in 1 line of complex treatment in patients with ovarian cancer (phase III clinicaL trial)

Summary. The results of clinical trials, which validate the efficacy and safety of administration of bevacizumab (Avastin) in first-line treatment of patients with ovarian cancer are presented.
No Comments » Add your
Leave a comment